Haemnet published new articles in Bleeding Disorders: Care & Practice including a plain language summary of real-world pharmacokinetics of albutrepenonacog alfa in haemophilia B, mental health needs in extremely rare bleeding disorders, and eptacog beta in perioperative haemostatic management during major surgery in people with haemophilia A and inhibitors on emicizumab prophylaxis.
Public source
Publisher name
Public post
💡All new articles published in Bleeding Disorders: Care & Practice now include a plain language summary, making it easier for everyone to find out about the latest blee…
Company
Haemnet
Research & Education | Content Creation | Stakeholder Engagement. Get in touch: hello@haemnet.com
- Industry
- Research Services
- Location
- London, GB
- Company size
- 2–10 employees
About Haemnet
Haemnet is a specialist research and communications consultancy. Our aim is to improve patient care by sharing experience; expanding knowledge.
See moreDiscover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
American Thrombosis and Hemostasis Network (ATHN)
American Thrombosis and Hemostasis Network (ATHN) published new research in Haemophilia providing real-world evidence on factor product switching, finding no new inhibitor development among previously treated people with hemophilia A or B following a factor product switch among participants with evaluable follow-up.
Research & Knowledge
National Bleeding Disorders Foundation
National Bleeding Disorders Foundation published an article exploring the benefits of period tracking apps, privacy concerns, and what women and girls with bleeding disorders should know before sharing sensitive health information.
Research & Knowledge
Hemab Therapeutics
Hemab Therapeutics is enrolling participants in two studies designed to advance understanding and treatment of Von Willebrand disease, including VELORA Discover and VELORA Pioneer.
Research & Knowledge
European Hematology Association (EHA)
European Hematology Association (EHA) published a new clinical case study titled Sickle Cell Disease Treatment - Case 1 examining the clinical assessment, investigation, and multidisciplinary management of a pregnant patient with SCD.
Research & Knowledge
American Society of Hematology